secwatch.observer — SEC 8-K summary
======================================

Issuer:     Serina Therapeutics, Inc. (SER)
CIK:        0001708599
Form:       8-K
Filed at:   2024-09-05T23:59:59+00:00
Accession:  0001493152-24-035028
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Serina Therapeutics to present at H.C. Wainwright conference on Sept 11
-----------------------------------------------------------------------

- Interim CEO Steve Ledger to present at H.C. Wainwright 26th Annual Global Investment Conference.
- Presentation scheduled for September 11, 2024 at 12:00 p.m. ET.
- Live webcast available via Investor section of Serina's website; replay available for limited time.
- Serina is a clinical-stage biotech developing POZ Platform drug delivery technology.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1708599/000149315224035028/0001493152-24-035028-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1708599/000149315224035028/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-035028

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer